Patents by Inventor Timothy J. Rink

Timothy J. Rink has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for regulating postprandial blood glucose
    Patent number: 7407934
    Abstract: Methods for treating conditions associated with elevated, inappropriate or undesired post-prandial blood glucose levels are disclosed which comprise administration of an effective amount of an amylin agonist alone or in conjunction with other anti-gastric emptying agents. Methods for reducing gastric motility and delaying gastric emptying for therapeutic and diagnostic purposes are also described.
    Type: Grant
    Filed: August 18, 2003
    Date of Patent: August 5, 2008
    Assignee: Amylin Pharmaceuticals, Inc.
    Inventors: Orville G. Kolterman, Andrew A. Young, Timothy J. Rink, Kathleen Ann Keating Brown
  • Methods for regulating gastrointestinal motility
    Publication number: 20040097415
    Abstract: Methods for treating conditions associated with elevated, inappropriate or undesired post-prandial blood glucose levels are disclosed which comprise administration of an effective amount of an amylin agonist alone or in conjunction with other anti-gastric emptying agents. Methods for reducing gastric motility and delaying gastric emptying for therapeutic and diagnostic purposes are also described.
    Type: Application
    Filed: August 18, 2003
    Publication date: May 20, 2004
    Inventors: Orville G. Kolterman, Andrew A. Young, Timothy J. Rink, Kathleen Ann Keating Brown
  • Methods for regulating gastrointestinal motility
    Patent number: 6608029
    Abstract: Methods for treating conditions associated with elevated, inappropriate or undesired post-prandial blood glucose levels are disclosed which comprise administration of an effective amount of an amylin agonist alone or in conjunction with other anti-gastric emptying agents. Methods for reducing gastric motility and delaying gastric emptying for therapeutic and diagnostic purposes are also described.
    Type: Grant
    Filed: May 22, 2000
    Date of Patent: August 19, 2003
    Assignee: Amylin Pharmaceuticals, Inc.
    Inventors: Orville G. Kolterman, Andrew A. Young, Timothy J. Rink, Kathleen Ann Keating Brown
  • Methods for regulating gastrointestinal motility
    Patent number: 6114304
    Abstract: Methods for treating conditions associated with elevated, inappropriate or undesired post-prandial blood glucose levels are disclosed which comprise administration of an effective amount of an amylin agonist alone or in conjunction with other anti-gastric emptying agents. Methods for reducing gastric motility and delaying gastric emptying for therapeutic and diagnostic purposes are also described.
    Type: Grant
    Filed: September 7, 1994
    Date of Patent: September 5, 2000
    Assignee: Amylin Pharmaceuticals, Inc.
    Inventors: Orville G. Kolterman, Andrew A. Young, Timothy J. Rink, Kathleen Ann Keiting Brown
  • Amylin activity assays
    Patent number: 6048514
    Abstract: Novel methods for use in identifying or assaying compounds which can simulate the ability of amylin to cause hyperlactemia and hyperglycemia in in vivo biological models, or for use in evaluating the potency of compounds known or suspected to simulate these actions of amylin, which involve introducing test samples into in vivo test systems and determining the presence or amount of a rise in lactate, or determining the presence or amount of a rise in lactate and a rise in glucose, following test sample administration.
    Type: Grant
    Filed: April 14, 1995
    Date of Patent: April 11, 2000
    Assignee: Amylin Pharmaceuticals, Inc.
    Inventors: Andrew A. Young, Garth J. S. Cooper, Timothy J. Rink
  • Method and composition for treatment of insulin requiring mammals
    Patent number: 5814600
    Abstract: Method and compositions for treating a mammal by administering to that mammal an insulin (having the in vitro activity of stimulating glucose incorporation into glycogen in rat soleus muscle) and an amylin (having the in vitro activity of suppressing glucose incorporation into glycogen in rat soleus muscle) using specific molar ratios of an insulin to an amylin.
    Type: Grant
    Filed: June 13, 1994
    Date of Patent: September 29, 1998
    Assignee: Amylin Pharmaceuticals Inc.
    Inventors: Timothy J. Rink, Andrew A. Young
  • Methods for regulating gastrointestinal motility
    Patent number: 5795861
    Abstract: Methods for treating conditions associated with elevated, inappropriate or undesired post-prandial blood glucose levels are disclosed which comprise administration of an effective amount of an amylin agonist alone or in conjunction with other anti-gastric emptying agents. Methods for reducing gastric motility and delaying gastric emptying for therapeutic and diagnostic purposes are also described.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: August 18, 1998
    Assignee: Amylin Pharmaceuticals Inc.
    Inventors: Orville G. Kolterman, Timothy J. Rink
  • Appetite regulating compositions
    Patent number: 5739106
    Abstract: Compositions and methods for reducing food intake, suppressing appetite and controlling body weight are provided. Such compositions may include an amylin agonist and a CCK agonist or a hybrid peptide.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: April 14, 1998
    Inventors: Timothy J. Rink, Andrew A. Young, Nigel Robert Arnold Beeley, Kathryn S. Prickett
  • Treatment of anorexia and related states
    Patent number: 5656590
    Abstract: Method for treatment of a patient suffering from anorexia or a related condition by administering amylin or an analogue thereof and/or to the patient in an amount sufficient to increase amylin and/or insulin levels in the plasma of the patient.
    Type: Grant
    Filed: November 24, 1993
    Date of Patent: August 12, 1997
    Assignee: Amylin Pharmaceuticals, Inc.
    Inventors: Timothy J. Rink, Andrew A. Young
  • Methods for treating renin-related disorders with amylin antagonists
    Patent number: 5376638
    Abstract: Methods for treating conditions associated with elevated, inappropriate or undesired renin activity are disclosed which comprise administration of an effective amount of any amylin antagonist alone or in conjunction with other anti-hypertensive agents. Methods for screening for and/or evaluating anti-renin amylin antagonists are also described.
    Type: Grant
    Filed: September 1, 1992
    Date of Patent: December 27, 1994
    Assignee: Amylin Pharmaceuticals, Inc.
    Inventors: Andrew A. Young, Timothy J. Rink
  • Receptor-based screening methods for amylin agonists and antagonists
    Patent number: 5264372
    Abstract: Methods for identifying or screening or characterizing or assaying or isolating known or candidate agonists and antagonists of amylin, comprising binding assays utilizing preparations containing specific receptors for amylin. Membranes from the brain that contain high density receptors for amylin are particularly useful for the methods of this invention, and as a source of amylin receptors.
    Type: Grant
    Filed: March 15, 1991
    Date of Patent: November 23, 1993
    Assignee: Amylin Pharmaceuticals, Inc.
    Inventors: Kevin Beaumont, Timothy J. Rink